Amit Sawant
Overview
Explore the profile of Amit Sawant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poirier Y, Byrne K, Hamad G, Therriault-Proulx F, Jiang K, Deng W, et al.
Radiat Res
. 2025 Mar;
PMID: 40073911
While biological studies of the FLASH effect in proton beams have mainly been performed in the plateau region at maximum beam energy and current, this type of delivery has limited...
2.
Ling X, Bazyar S, Ferris M, Molitoris J, Allor E, Thomas H, et al.
Sci Rep
. 2025 Feb;
15(1):6358.
PMID: 39984635
No abstract available.
3.
Ling X, Bazyar S, Ferris M, Molitoris J, Allor E, Thomas H, et al.
Sci Rep
. 2025 Jan;
15(1):1279.
PMID: 39779914
This study addresses the limited noninvasive tools for Head and Neck Squamous Cell Carcinoma (HNSCC) progression-free survival (PFS) prediction by identifying Computed Tomography (CT)-based biomarkers for predicting prognosis. A retrospective...
4.
Sawant A, Kanji N, DiMare M, Matusow D, Edelstein S, Menakuru S
Drug Dev Ind Pharm
. 2024 Dec;
51(1):29-37.
PMID: 39686557
Objective: This pilot study aimed to develop a liquid formulation of tenapanor and evaluate taste and palatability with different sweetener and flavor combinations. Significance: Tenapanor is a first-in-class, minimally absorbed,...
5.
Wang J, Deek M, Mendes A, Song Y, Shetty A, Bazyar S, et al.
Radiother Oncol
. 2024 Nov;
202:110618.
PMID: 39510141
Background: There is a need for clinically actionable prognostic and predictive tools to guide the management of oligometastatic castration-sensitive prostate cancer (omCSPC). Methods: This is a multicenter retrospective study to...
6.
Modiri A, Mossahebi S, Sawant A, Chen S, Zhang B, Yi B
Phys Med
. 2024 Oct;
127:104829.
PMID: 39368298
Purpose: To explore the feasibility of a novel intensity-modulated proton arc technique that uses a single-energy beam from the cyclotron. The beam energy is externally modulated at each gantry angle...
7.
Cao Y, Sutera P, Mendes W, Yousefi B, Hrinivich T, Deek M, et al.
Radiother Oncol
. 2024 Aug;
199:110443.
PMID: 39094629
Purpose: This study investigated imaging biomarkers derived from PSMA-PET acquired pre- and post-metastasis-directed therapy (MDT) to predict 2-year metastasis-free survival (MFS), which provides valuable early response assessment to improve patient...
8.
Mossahebi S, Byrne K, Jiang K, Gerry A, Deng W, Repetto C, et al.
Phys Med Biol
. 2024 Jun;
69(14).
PMID: 38876112
. To fabricate and validate a novel focused collimator designed to spare normal tissue in a murine hemithoracic irradiation model using 250 MeV protons delivered at ultra-high dose rates (UHDRs)...
9.
Sutera P, Song Y, Shetty A, English K, Van der Eecken K, Guler O, et al.
Eur Urol Oncol
. 2024 Jun;
8(1):111-118.
PMID: 38862340
Background And Objective: Oligometastatic castration-sensitive prostate cancer (omCSPC) represents an early state in the progression of metastatic disease for which patients experience better outcomes in comparison to those with higher...
10.
Vicente E, Grande Gutierrez N, Oakes J, Cammin J, Gopal A, Kipritidis J, et al.
Med Phys
. 2024 May;
51(9):6259-6275.
PMID: 38820385
Background: Investigations on radiation-induced lung injury (RILI) have predominantly focused on local effects, primarily those associated with radiation damage to lung parenchyma. However, recent studies from our group and others...